S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
52-week Low Names To Tip The Upside Scale In Your Favor
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Reasons This Sleeping Giant Is About To Wake Up
KB Home Price Weakness is a Signal to Buy this Cash Machine
Laser breakthrough could send stock soaring 2,467% (Ad)
Things to know about California's new proposed rules for insurance companies
Analysts Went All In On These Computer Stocks, Save Your Spot
Overlooked AI Stock Gets Urgent "Buy" (Ad)
MarketBeat Week in Review – 9/18 - 9/22
How major US stock indexes fared Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
52-week Low Names To Tip The Upside Scale In Your Favor
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Reasons This Sleeping Giant Is About To Wake Up
KB Home Price Weakness is a Signal to Buy this Cash Machine
Laser breakthrough could send stock soaring 2,467% (Ad)
Things to know about California's new proposed rules for insurance companies
Analysts Went All In On These Computer Stocks, Save Your Spot
Overlooked AI Stock Gets Urgent "Buy" (Ad)
MarketBeat Week in Review – 9/18 - 9/22
How major US stock indexes fared Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
52-week Low Names To Tip The Upside Scale In Your Favor
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Reasons This Sleeping Giant Is About To Wake Up
KB Home Price Weakness is a Signal to Buy this Cash Machine
Laser breakthrough could send stock soaring 2,467% (Ad)
Things to know about California's new proposed rules for insurance companies
Analysts Went All In On These Computer Stocks, Save Your Spot
Overlooked AI Stock Gets Urgent "Buy" (Ad)
MarketBeat Week in Review – 9/18 - 9/22
How major US stock indexes fared Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
52-week Low Names To Tip The Upside Scale In Your Favor
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Reasons This Sleeping Giant Is About To Wake Up
KB Home Price Weakness is a Signal to Buy this Cash Machine
Laser breakthrough could send stock soaring 2,467% (Ad)
Things to know about California's new proposed rules for insurance companies
Analysts Went All In On These Computer Stocks, Save Your Spot
Overlooked AI Stock Gets Urgent "Buy" (Ad)
MarketBeat Week in Review – 9/18 - 9/22
How major US stock indexes fared Friday, 9/22/2023
OTCMKTS:DSRLF

DiaSorin (DSRLF) Stock Forecast, Price & News

$91.00
-0.60 (-0.66%)
(As of 09/22/2023 ET)
Compare
Today's Range
$91.00
$91.00
50-Day Range
$91.00
$97.98
52-Week Range
$91.00
$147.15
Volume
35 shs
Average Volume
13 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$201.25

DSRLF stock logo

About DiaSorin (OTCMKTS:DSRLF) Stock

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

DSRLF Price History

DSRLF Stock News Headlines

DiaSorin S.p.A. reports 1H results
U.S. "Shadow Banks" About to Blow up again?
Analyst who called Lehman crash says our biggest calamities (1907, 1929, 2007, etc) all start in the same spot--and it’s about to happen again. More here.
DiaSorin S.p.A.
DiaSorin: Overvalued Italian Healthcare Company
U.S. "Shadow Banks" About to Blow up again?
Analyst who called Lehman crash says our biggest calamities (1907, 1929, 2007, etc) all start in the same spot--and it’s about to happen again. More here.
DiaSorin To Buy Luminex For $1.8 Bln
DiaSorin S.p.A. reports FY results
See More Headlines
Receive DSRLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DiaSorin and its competitors with MarketBeat's FREE daily newsletter.

DSRLF Company Calendar

Today
9/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:DSRLF
CIK
N/A
Fax
N/A
Employees
3,358
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$201.25
High Stock Price Forecast
$201.25
Low Stock Price Forecast
$201.25
Forecasted Upside/Downside
+119.7%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
6 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.46 billion
Cash Flow
$9.80 per share
Book Value
$29.58 per share

Miscellaneous

Free Float
N/A
Market Cap
$5.01 billion
Optionable
Not Optionable
Beta
0.39
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Carlo Rosa (Age 57)
    CEO, GM & Exec. Director
    Comp: $1.88M
  • Dr. Chen Menachem Even (Age 60)
    Chief Commercial Officer, Sr. Corp. VP of Commercial Operations & Exec. Director
    Comp: $919.27k
  • Mr. Piergiorgio Pedron (Age 52)
    Sr. Corp. VP, CFO & Corp. Accounting Documents Officer
  • Mr. Fabrizio Piercarlo Bonelli
    Corp. VP & Chief Technology Officer
  • Dr. Riccardo Fava
    Corp. VP of Communication & Investor Relations
  • Mr. Ulisse Spada
    Corp. VP, Head of the Legal Department, Sec. & Gen. Counsel
  • Mr. Stefano Ronchi (Age 63)
    Sr. Corp. VP of HR
  • Mr. Ugo Gay (Age 58)
    Chief Exec. Officer of DiaSorin Italia S.p.A.
  • Mr. Angelo Rago (Age 60)
    Pres of Luminex Corp.













DSRLF Stock - Frequently Asked Questions

Should I buy or sell DiaSorin stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DiaSorin in the last twelve months. There are currently 3 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" DSRLF shares.
View DSRLF analyst ratings
or view top-rated stocks.

What is DiaSorin's stock price forecast for 2023?

6 brokerages have issued twelve-month target prices for DiaSorin's stock. Their DSRLF share price forecasts range from $201.25 to $201.25. On average, they anticipate the company's stock price to reach $201.25 in the next year. This suggests a possible upside of 119.7% from the stock's current price.
View analysts price targets for DSRLF
or view top-rated stocks among Wall Street analysts.

How have DSRLF shares performed in 2023?

DiaSorin's stock was trading at $147.15 at the beginning of 2023. Since then, DSRLF stock has decreased by 37.8% and is now trading at $91.5995.
View the best growth stocks for 2023 here
.

What is DiaSorin's stock symbol?

DiaSorin trades on the OTCMKTS under the ticker symbol "DSRLF."

How do I buy shares of DiaSorin?

Shares of DSRLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DiaSorin's stock price today?

One share of DSRLF stock can currently be purchased for approximately $91.60.

How much money does DiaSorin make?

DiaSorin (OTCMKTS:DSRLF) has a market capitalization of $5.01 billion and generates $1.46 billion in revenue each year.

How many employees does DiaSorin have?

The company employs 3,358 workers across the globe.

How can I contact DiaSorin?

DiaSorin's mailing address is Via Crescentino, Saluggia L6, 13040. The official website for the company is www.diasoringroup.com. The company can be reached via phone at 391614871 or via email at ines.diterlizzi@diasorin.it.

This page (OTCMKTS:DSRLF) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -